Inhibrx: All non-101 assets and liabilities will be spun off from the company to a new listed company Inhibrx Biosciences before the merger ends

Inhibrx: All non-101 assets and liabilities will be spun off from the company to a new listed company Inhibrx Biosciences before the merger ends

Zhitong FinanceMay 25 04:03

Express News | Inhibrx: Prior to Closing of Merger, All Non-101 Assets & Liabilities Will Be Spun Out From Co Into a New Publicly Traded Company, Inhibrx Biosciences

BreakingsMay 25 04:01

Inhibrx Inc. shareholders approve sale of Inbrx-101 to Sanofi

Inhibrx Inc. shareholders approve sale of Inbrx-101 to Sanofi

Zhitong FinanceMay 25 04:00

Express News | Inhibrx Inc. Stockholders Approve Sale of Inbrx-101 to Sanofi

BreakingsMay 25 04:00

Form 144 | Inhibrx(INBX.US) Officer Proposes to Sell 170.94K in Common Stocks

SEC FILLINGS DISCLOSED/ May 22, $Inhibrx(INBX.US)$ Officer Eckelman Brendan P. intends to sell 5,010 shares of its common stock on May 22, with a total market value of approximately $170.94K. Eckelm

Futu NewsMay 22 22:00

JMP Securities Remains a Hold on Inhibrx (INBX)

TipRanksMay 13 22:06